𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Polysomnography in preterm infants and children with chronic lung disease

✍ Scribed by Sharon A. McGrath-Morrow; Timothy Ryan; Brian M. McGinley; Sande O. Okelo; Laura M. Sterni; J. Michael Collaco


Publisher
John Wiley and Sons
Year
2011
Tongue
English
Weight
88 KB
Volume
47
Category
Article
ISSN
8755-6863

No coin nor oath required. For personal study only.

✦ Synopsis


Objective:

To determine the utility of overnight polysomnography (psg) in assessing pulmonary reserve in stable preterm children with chronic lung disease (cld).

Study design:

A retrospective review and descriptive study of overnight psgs and clinic visits of preterm infants/children less than 3 years of age who were diagnosed with bronchopulmonary dysplasia at discharge from the hospital and enrolled in the johns hopkins cld patient registry between 2008 and 2010.

Results:

Sixty-two clinically stable patients underwent at least one overnight polysomnogram for clinical indications. the majority of patients were referred for oxygen titration (71%). psgs from first studies revealed a mean respiratory disturbance index (rdi) of 8.2 ± 10.1 events/hr and a mean o(2) saturation (sao(2) ) nadir of 86.2 ± 5.7%. in patients who underwent more than one psg (n = 23), a significant decrease in rdi (p < 0.001) was found between the first study (mean age: 8.0 ± 3.3 months) and second study (mean age: 13.4 ± 5.2 months). outpatient clinical measures of mean room air sao(2) and respiratory rate were not predictive of psg measures of rdi and sao(2) nadir.

Conclusion:

Mean rdi was higher in stable preterm infants/children with cld compared to previously published controls. rdi decreased with age in stable preterm infants/children with cld suggesting improved pulmonary reserve with age. outpatient clinical measures (respiratory rate and room air sao(2) ) did not correlate with rdi and sao(2) nadir indicating that overnight psg is more sensitive in assessing pulmonary reserve than outpatient clinical measures.


πŸ“œ SIMILAR VOLUMES


Prevention of chronic lung disease in pr
✍ Yuh J. Lin; Tsu F. Yeh; Wu S. Hsieh; Yun C. Chi; Hong C. Lin; Chyi H. Lin πŸ“‚ Article πŸ“… 1999 πŸ› John Wiley and Sons 🌐 English βš– 48 KB πŸ‘ 2 views

Recent studies suggest that early dexamethasone therapy may lessen the pulmonary inflammation in preterm infants with respiratory distress syndrome (RDS). To investigate whether early (<12 hr) postnatal dexamethasone therapy would reduce the incidence of chronic lung disease (CLD), a randomized, dou

Effects of inhaled beclomethasone compar
✍ P. Groneck; B. Goetze-Speer; C.P. Speer πŸ“‚ Article πŸ“… 1999 πŸ› John Wiley and Sons 🌐 English βš– 57 KB πŸ‘ 2 views

The purpose of this study was to compare the effects of daily inhaled beclomethasone (3 Γ— 500 Β΅g) started on day 3 of life, with that of systemic dexamethasone (0.5 mg/kg/day) started between days 11-13 on clinical variables, lung inflammation, and pulmonary microvascular permeability in preterm inf